The risk of peritonitis associated with infections of the peritoneal catheter exit site can be reduced by the use of proper exit-site care, such as the routine administration of prophylactic antibiotics at the exit site. Studies that demonstrate the efficacy of such an approach or similar approaches continue to be published.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chua, A. N., Goldstein, S. L., Bell, D. & Brewer, E. D. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin. J. Am. Soc. Nephrol. 4, 1939–1943 (2009).
Johnson, D. W. et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am. J. Kidney Dis. 53, 290–297 (2009).
Davenport, A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit. Dial. Int. 29, 297–302 (2009).
Swartz, R., Messana, J., Starmann, B., Weber. M. & Reynolds, J. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J. Am. Soc. Nephrol. 2, 1085–1091 (1991).
Gupta, B., Bernardini, J. & Piraino, B. Peritonitis associated with exit site and tunnel infections. Am. J. Kidney Dis. 28, 415–419 (1996).
Zimmerman, S. W. et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am. J. Kidney Dis. 18, 225–231 (1991).
Bernardini, J., Piraino, B., Holley, J., Johnston, J. R. & Lutes, R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am. J. Kidney Dis. 27, 695–700 (1996).
Bernardini, J. et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J. Am. Soc. Nephrol. 16, 539–545 (2005).
Pérez-Fontan, M., Rosales, M., Rodríguez-Carmona, A., Falcón, T. G. & Valdés, F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am. J. Kidney Dis. 39, 337–341 (2002).
Annigeri, R. et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int. 21, 554–559 (2001).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Piraino, B. The importance of peritoneal catheter exit-site care. Nat Rev Nephrol 6, 259–260 (2010). https://doi.org/10.1038/nrneph.2010.45
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2010.45
This article is cited by
-
Catheter-related infections in peritoneal dialysis: comparison of a single center results and the literature data
Journal of Nephrology (2019)
